科兴生物(SVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SVA 科兴生物

停牌 04-26 17:23:17 EDT

6.47

+0.00

0.00%

最高6.47	最低6.47	成交量0.00
今开6.47	昨收6.47	日振幅0.00%
总市值6.42亿	流通市值3.85亿	总股本9,929万
成交额0.00	换手率0.00%	流通股本5,951万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SVA","market":"US","secType":"STK","nameCN":"科兴生物","latestPrice":6.47,"timestamp":1714161600000,"preClose":6.47,"halted":3,"volume":0,"delay":0,"floatShares":59508401,"shares":99294743,"eps":0.971025,"marketStatus":"停牌","marketStatusCode":4,"change":0,"latestTime":"04-26 17:23:17 EDT","open":6.47,"high":6.47,"low":6.47,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.971025,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1714176000000},"adr":0,"listingDate":1102482000000,"adjPreClose":6.47,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/SVA","defaultTab":"news","newsList":[{"id":"2430425225","title":"投资兴盟生物，科兴生物进入创新抗体药物新领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2430425225","media":"界面","top":-1,"share":"https://www.laohu8.com/m/news/2430425225?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:53","pubTimestamp":1714125224,"startTime":"0","endTime":"0","summary":"据科兴生物消息，4月26日，在2024苏州全球招商大会上，科兴控股生物技术有限公司（以下称“SINOVAC科兴”）高级总监兼兴盟生物医药（苏州）有限公司（以下称“兴盟生物”）常务副总经理公雪杰代表公司与苏州工业园区就“兴盟抗体研发制造基地”项目签约。此前，SINOVAC科兴已完成对兴盟生物的投资。据介绍，兴盟生物自主研制的国内首个符合世界卫生组织推荐的抗狂犬病鸡尾酒单克隆抗体组合制剂泽美洛韦玛佐瑞韦单抗克瑞毕®年内有望在国内上市，并将于近期向美国FDA递交生物制品许可申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261753447923d7eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261753447923d7eb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420808710","title":"科兴制药：GB08注射液临床试验注册申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2420808710","media":"澎湃新闻","top":-1,"share":"https://www.laohu8.com/m/news/2420808710?lang=zh_cn&edition=full","pubTime":"2024-03-20 19:13","pubTimestamp":1710933180,"startTime":"0","endTime":"0","summary":"3月20日晚间，科兴生物制药股份有限公司公告，近日，全资子公司深圳科兴收到国家药品监督管理局行政许可文书《受理通知书》，深圳科兴申报的“GB08注射液”临床试验申请已获得受理。该药品适应症为治疗儿童生长激素缺乏症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403201914208b4c3c7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403201914208b4c3c7d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415773512","title":"科兴生物1.49亿回购988.5万股 占总股本0.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415773512","media":"观点新媒体","top":-1,"share":"https://www.laohu8.com/m/news/2415773512?lang=zh_cn&edition=full","pubTime":"2024-02-29 19:27","pubTimestamp":1709206039,"startTime":"0","endTime":"0","summary":"观点网讯：2月29日，科兴生物制药股份有限公司公布股份回购进展。截至2024年2月29日，该公司通过上海证券交易所交易系统累计回购988480股，占总股本的0.50%，成交价区间在14.30-15.68元/股，支付总额约1.489亿元。此次回购股份用于维护公司价值和股东权益，回购方案已于2024年2月22日由第二届董事会第十二次会议审议通过。根据方案，回购资金规模在3000万至6000万元之间，回购价格不超过26.08元/股，回购期限为董事会审议通过之日起3个月内。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402291938388af03698&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402291938388af03698&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415051272","title":"科兴生物公布高管团队增持股份进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2415051272","media":"观点新媒体","top":-1,"share":"https://www.laohu8.com/m/news/2415051272?lang=zh_cn&edition=full","pubTime":"2024-02-29 19:27","pubTimestamp":1709206039,"startTime":"0","endTime":"0","summary":"观点网讯：2月29日，科兴生物制药股份有限公司发布实际控制人兼董事长邓学勤先生等一众董事及高级管理人员增持公司股份的进展公告。截至2024年2月29日，邓学勤先生已增持762,710股，占总股本0.38%，耗资1000.92万元；赵彦轻先生增持76,136股，占比0.04%，耗资104.93万元；邵珂先生、王小琴女士、马鸿杰女士及崔宁女士等也分别完成增持，各自增持金额均已超过增持计划下限。目前增持计划尚未完成，相关增持主体将继续执行增持计划。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022919384287d1acca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022919384287d1acca&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404657969","title":"新冠疫苗停产后拒被“抄底”：科兴生物向资本要约收购说“NO”","url":"https://stock-news.laohu8.com/highlight/detail?id=2404657969","media":"21财经","top":-1,"share":"https://www.laohu8.com/m/news/2404657969?lang=zh_cn&edition=full","pubTime":"2024-01-20 09:17","pubTimestamp":1705713420,"startTime":"0","endTime":"0","summary":"在截至2023年6月30日的六个月期间，科兴生物公布归属于普通股股东的净收入1400万美元，即每股0.14美元和每股摊薄0.15美元。最后，科兴生物董事会也注意到，收购要约可因各种原因进行修改，存在“陷阱”。随着新冠疫情渐行渐远，新冠防治相关市场需求逐渐萎缩，科兴生物业绩也出现快速滑落。虽然停产了新冠疫苗，但科兴制药在新冠业务方面仍有布局。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240120092155790a803b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240120092155790a803b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404586094","title":"科兴生物董事会建议股东拒绝Alternative Liquidity的要约收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2404586094","media":"界面","top":-1,"share":"https://www.laohu8.com/m/news/2404586094?lang=zh_cn&edition=full","pubTime":"2024-01-18 20:47","pubTimestamp":1705582036,"startTime":"0","endTime":"0","summary":"1月18日，科兴控股生物技术有限公司发布公告称，董事会一致决定，Alternative Liquidity Index LP提出的以每股0.03美元现金收购至多1000万股Sinovac普通股的部分要约收购不可取，也不符合公司的最佳利益。因此，董事会建议股东拒绝接受要约收购，不根据Alternative Liquidity的收购要约投标其股份。根据公告，Alternative Liquidity承认，它没有任何准确的方法来确定公司股份的现值。科兴董事会认为，这说明Alternative Liquidity的估值方法缺乏可信度，要约收购价格也不充分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401182047167a3c4c5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401182047167a3c4c5d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402937214","title":"科兴生物新冠疫苗停产背后：市场需求照进现实","url":"https://stock-news.laohu8.com/highlight/detail?id=2402937214","media":"澎湃新闻","top":-1,"share":"https://www.laohu8.com/m/news/2402937214?lang=zh_cn&edition=full","pubTime":"2024-01-12 19:10","pubTimestamp":1705057828,"startTime":"0","endTime":"0","summary":"·科兴生物的新冠灭活疫苗“克尔来福”是中国最早获批使用的新冠疫苗之一，这款疫苗曾在2021年销售超千亿元。科兴之前，已有多家企业暂停新冠疫苗的生产，或者停止对新冠疫苗的进一步开发投入。而2023年半年报显示，科兴生物上半年的销售额为1.4亿美元，同比下降88%，净利润为1692万美元，同比下降96.51%，主要原因是新冠疫苗“克尔来福”的销售减少。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011219105687b38a53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011219105687b38a53&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"1116585753","title":"热搜爆了！科兴新冠疫苗停产，曾一年销售超千亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1116585753","media":"券商中国","top":-1,"share":"https://www.laohu8.com/m/news/1116585753?lang=zh_cn&edition=full","pubTime":"2024-01-11 08:17","pubTimestamp":1704932232,"startTime":"0","endTime":"0","summary":"据了解，科兴的新冠疫苗克尔来福是国内最早获批使用的新冠疫苗之一，这款疫苗曾在2021年销售超千亿元，而随着新冠疫情的消退，新冠疫苗的销量也随之大幅下降。科兴新冠疫苗已停产1月10日下午，话题#科兴新冠疫苗已停产#冲上热搜第一，引发不少网友讨论。科兴的新冠疫苗，是国产新冠疫苗中销售额数一数二的品种，是全球范围内使用最广泛的新冠疫苗之一。在“科兴新冠疫苗停产”之前，已有厂家暂停新冠疫苗的生产。","market":"hk","thumbnail":"https://static.tigerbbs.com/6e474d690ea02c536f0fd4c03fc3ddef","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6e474d690ea02c536f0fd4c03fc3ddef"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"gpt_icon":1},{"id":"2402511122","title":"科兴新冠疫苗已全部停产，工作人员表回应！目前各地还有多款新冠疫苗可注射","url":"https://stock-news.laohu8.com/highlight/detail?id=2402511122","media":"虎嗅","top":-1,"share":"https://www.laohu8.com/m/news/2402511122?lang=zh_cn&edition=full","pubTime":"2024-01-10 16:55","pubTimestamp":1704876900,"startTime":"0","endTime":"0","summary":"目前各地还有多款新冠疫苗可注射。近日，1，一份名为“停发新冠项目绩效工资方案”的文件在网上传播，落款为北京科兴中维生物技术公司，其中提到公司新冠疫苗已全部停产且公司目前也无新冠疫苗产品销售。科兴控股生物技术有限公司产品咨询热线工作人员表示，科兴的新冠疫苗确已停产，如果还需注射该产品，要询问当地疾控中心，是否有库存。此外，还包括万泰生物的病毒载体鼻喷新冠疫苗以及石药集团mRNA疫苗SYS6006。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401101655297907af5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401101655297907af5f&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinovac.com;www.sinovac.com.cn","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":-0.0295},{"period":"3month","weight":0.033},{"period":"6month","weight":0.226},{"period":"1year","weight":0.2452},{"period":"ytd","weight":0.0593}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"科兴控股生物技术有限公司于1999年3月1日在安提瓜和巴布达注册成立，是一家总部位于北京的生物高新技术企业。公司主要从事于研究，开发，制造及保护免受感染性疾病的疫苗。公司还曾先后研制出全球第一支SARS冠状病毒灭活疫苗（完成I期临床研究）、中国第一支大流行流感（H5N1）疫苗以及全球第一支甲型H1N1流感疫苗，为中国乃至全球疾病预防控制做出了贡献。公司正在开发一系列新产品，包括Sabin株脊髓灰质炎灭活疫苗、23价肺炎球菌多糖疫苗、新型冠状病毒灭活疫苗及多个联合疫苗等。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.027083},{"month":2,"riseRate":0.7,"avgChangeRate":0.044011},{"month":3,"riseRate":0.777778,"avgChangeRate":0.016157},{"month":4,"riseRate":0.1,"avgChangeRate":-0.045415},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.034293},{"month":6,"riseRate":0.444444,"avgChangeRate":0.023452},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.027021},{"month":8,"riseRate":0.444444,"avgChangeRate":0.025862},{"month":9,"riseRate":0.666667,"avgChangeRate":0.007361},{"month":10,"riseRate":0.666667,"avgChangeRate":0.018455},{"month":11,"riseRate":0.666667,"avgChangeRate":0.055242},{"month":12,"riseRate":0.3,"avgChangeRate":-0.010006}],"exchange":"NASDAQ","name":"科兴生物","nameEN":"Sinovac Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科兴生物(SVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科兴生物(SVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科兴生物,SVA,科兴生物股票,科兴生物股票老虎,科兴生物股票老虎国际,科兴生物行情,科兴生物股票行情,科兴生物股价,科兴生物股市,科兴生物股票价格,科兴生物股票交易,科兴生物股票购买,科兴生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科兴生物(SVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科兴生物(SVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}